Preventing Respiratory Tract Disease in Newborns: ‘Abrysvo’ Immunization by Pfizer

2023-08-22 11:52:33

Microbiology and Infectious Diseases – ‘Abrysvo’, from Pfizer

‘Abrysvo’, by Pfizer

Its administration between weeks 32 and 36 prevents severe lower respiratory tract disease in babies in their first three months of life by more than 90%.

Immunization of pregnant women once morest RSV has shown great benefit for babies.
1692707177
#approves #RSV #vaccine #pregnant #women